Back to Search
MARK WEINBLATT, M.D.
M.D.
Pediatric Hematology & Oncology Physician
NPI: 1407860570Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
131240(NY)
Research & Publications (20)
The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis.
PMID 19479876·Arthritis Rheum·2009
8-other
TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma.
PMID 19455057·J Clin Rheumatol·2009
5-case
Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn disease.
PMID 19516196·J Pediatr Gastroenterol Nutr·2009
5-case
Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.
PMID 19193698·Rheumatology (Oxford)·2009
8-other
Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
PMID 19228655·J Rheumatol·2009
8-other
De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot.
PMID 19597493·Nat Genet·2009
8-other
Case records of the Massachusetts General Hospital. Case 13-2009. A 54-year-old woman with respiratory failure and a cavitary lesion in the lung.
PMID 19387019·N Engl J Med·2009
5-case
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
PMID 18791055·Ann Rheum Dis·2008
8-other
Common variants at CD40 and other loci confer risk of rheumatoid arthritis.
PMID 18794853·Nat Genet·2008
4-observational
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
PMID 18821648·Arthritis Rheum·2008
6-review
Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
PMID 18576334·Arthritis Rheum·2008
4-observational
When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
PMID 18854512·Ann Rheum Dis·2008
8-other
Questions and answers in 2008 about biologics in rheumatoid arthritis.
PMID 18785296·J Rheumatol·2008
8-other
Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis.
PMID 18657665·Am Heart J·2008
8-other
Severe nontuberculous mycobacterial infection in 2 patients receiving rituximab for refractory myositis.
PMID 18671331·J Rheumatol·2008
5-case
Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study.
PMID 18717997·Arthritis Res Ther·2008
4-observational
Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis.
PMID 18634159·J Rheumatol·2008
8-other
Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial.
PMID 18975322·Arthritis Rheum·2008
2-rct
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.
PMID 19022808·Ann Rheum Dis·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 120 MINEOLA BLVD, SUITE 460
MINEOLA, NY 11501 - Phone
- (516) 663-9400
Quick Facts
- NPI
- 1407860570
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile